HRMY vs. EWY

Last updated Jun 5, 2026

HRMY (Harmony Biosciences Holdings, Inc.) is a stock, while EWY (iShares MSCI South Korea ETF) is Asia Pacific Equities fund tracking the MSCI Korea Index. Over the past 5 years, HRMY returned -0.14%/yr vs 19.28%/yr for EWY. At a 0.15 correlation, their price movements are largely independent.

Performance

HRMY vs. EWY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and iShares MSCI South Korea ETF (EWY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HRMY achieves a -11.92% return, which is significantly lower than EWY's 109.80% return.

HRMY

• 1D: 2.68%
• 1M: 1.92%
• YTD: -11.92%
• 6M: -13.83%
• 1Y: -6.26%
• 3Y*: -2.41%
• 5Y*: -0.14%
• 10Y*: —

EWY

• 1D: -4.22%
• 1M: 17.58%
• YTD: 109.80%
• 6M: 127.01%
• 1Y: 225.96%
• 3Y*: 49.84%
• 5Y*: 19.28%
• 10Y*: 16.82%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HRMY vs. EWY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
HRMY Harmony Biosciences Holdings, Inc.	-11.92%	8.75%	6.53%	-41.38%	29.22%	17.95%	-2.32%
EWY iShares MSCI South Korea ETF	109.80%	95.33%	-20.48%	19.05%	-26.59%	-7.58%	34.77%

Correlation

The correlation between HRMY and EWY is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Aug 20, 2020	0.15

Return for Risk

HRMY vs. EWY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRMY

HRMY Risk / Return Rank: 34
HRMY Sharpe Ratio Rank: 35
HRMY Sortino Ratio Rank: 32
HRMY Omega Ratio Rank: 32
HRMY Calmar Ratio Rank: 35
HRMY Martin Ratio Rank: 35

EWY

EWY Risk / Return Rank: 96
EWY Sharpe Ratio Rank: 98
EWY Sortino Ratio Rank: 94
EWY Omega Ratio Rank: 94
EWY Calmar Ratio Rank: 96
EWY Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRMY vs. EWY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and iShares MSCI South Korea ETF (EWY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HRMY	EWY	Difference
Sharpe ratio: Return per unit of total volatility	-0.15	5.38	-5.53
Sortino ratio: Return per unit of downside risk	0.07	4.95	-4.87
Omega ratio: Gain probability vs. loss probability	1.01	1.69	-0.67
Calmar ratio: Return relative to maximum drawdown	-0.18	9.86	-10.04
Martin ratio: Return relative to average drawdown	-0.33	36.63	-36.97
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HRMY vs. EWY - Sharpe Ratio Comparison

The current HRMY Sharpe Ratio is -0.15, which is lower than the EWY Sharpe Ratio of 5.38. The chart below compares the historical Sharpe Ratios of HRMY and EWY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HRMY	EWY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.15	5.38	-5.53
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.00	0.67	-0.67
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.62	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	0.33	-0.37

Drawdowns

HRMY vs. EWY - Drawdown Comparison

The maximum HRMY drawdown since its inception was -68.48%, smaller than the maximum EWY drawdown of -74.14%. Use the drawdown chart below to compare losses from any high point for HRMY and EWY.

Drawdown Indicators

	HRMY	EWY	Difference
Max Drawdown Largest peak-to-trough decline	-68.48%	-74.14%	+5.66%
Max Drawdown (1Y) Largest decline over 1 year	-34.49%	-23.08%	-11.41%
Max Drawdown (3Y) Largest decline over 3 years	-50.81%	-27.36%	-23.45%
Max Drawdown (5Y) Largest decline over 5 years	-68.48%	-48.55%	-19.93%
Max Drawdown (10Y) Largest decline over 10 years	—	-49.73%	—
Current Drawdown Current decline from peak	-45.89%	-5.87%	-40.02%
Average Drawdown Average peak-to-trough decline	-35.21%	-20.12%	-15.09%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.73%	6.20%	+12.53%

Volatility

HRMY vs. EWY - Volatility Comparison

The current volatility for Harmony Biosciences Holdings, Inc. (HRMY) is 10.38%, while iShares MSCI South Korea ETF (EWY) has a volatility of 20.44%. This indicates that HRMY experiences smaller price fluctuations and is considered to be less risky than EWY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HRMY	EWY	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.38%	20.44%	-10.06%
Volatility (6M) Calculated over the trailing 6-month period	30.25%	37.73%	-7.48%
Volatility (1Y) Calculated over the trailing 1-year period	41.48%	42.37%	-0.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.05%	28.89%	+21.16%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	52.39%	27.40%	+24.99%

Dividends

HRMY vs. EWY - Dividend Comparison

HRMY has not paid dividends to shareholders, while EWY's dividend yield for the trailing twelve months is around 1.00%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EWY iShares MSCI South Korea ETF	1.00%	2.10%	2.55%	2.52%	1.23%	2.16%	0.73%	2.10%	1.34%	2.90%	1.21%	2.42%
HRMY Harmony Biosciences Holdings, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both HRMY and EWY in my portfolio?

HRMY and EWY have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HRMY or EWY?

EWY has higher volatility (20.44%) compared to HRMY (10.38%). In terms of maximum drawdown, HRMY dropped -68.48% vs EWY's -74.14%.

Which has better risk-adjusted returns?

EWY currently has the higher Sharpe Ratio (5.38 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.